Two Sigma Advisers’s Boston Scientific BSX Stock Holding History

Two Sigma Advisers’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-12,000	Closed	-$153K	–	2349
2014 Q2	$153K	Buy	+12,000	New	+$156K	﹤0.01%	2319

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Two Sigma Advisers's BSX Position: Q1 2026 in Review

Two Sigma Advisers sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 6,298,460 shares — an estimated $601M sold.

Two Sigma Advisers first reported a position in BSX in Q2 2013 and held it in 45 quarters. The position peaked at $601M in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Two Sigma Advisers reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
Two Sigma Advisers sold 6,298,460 Boston Scientific shares in Q1 2026, an estimated $601M.
Two Sigma Advisers first reported a position in Boston Scientific in Q2 2013 and held it in 45 quarters.
Two Sigma Advisers's Boston Scientific position peaked at $601M in Q4 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.